San Fran,

They will be attending the Alzheimer's Association Research Roundtable 7/18 to 7/23 and attending(and presenting) at the EpiCongress 7/22-7/24. Furthermore, according to the most recent NR, "Resverlogix Closes License Agreement and Enters Into Definitive Stock Purchase Agreement With Hepalink." Ronrydell on the other board posted about an email Sarah sent him yesterday "When the deal closes it will be announcement via a public news release." The definitive agreements must be executed by 7/26, according to the original Hepalink NR.

I agree I would love to hear an update. However, let's cut them a little slack through the end of the month for them to get these conferences out of the way and the Hepalink agreement executed. Additionally, RVX has stated before that additionally BETonMACE trial details won't be disclosed until the the trial is announced. So they seem to be staying true to their word with the exception of the vague and confusing European Regulatory Authority NR.

Best,

BDAZ